无菌性翻修全膝关节置换术中对称与非对称胫骨垫块生存率的比较
本研究比较了无菌性翻修全膝关节置换术中采用对称或非对称模块化胫骨垫块患者的影像学透亮线与5年无翻修生存率。共纳入76例对称垫块和27例非对称垫块患者,平均随访分别为3.5年和4.4年。两组透亮线发生率相似(44.7%对44.4%,P=1.0),但非对称组5年全因及非感染性无翻修生存率均低于对称组(56.1%对85.5%,P=0.021;64.8%对89%,P=0.019)。
要点
- 对称与非对称胫骨垫块组影像学透亮线发生率相似(44.7%对44.4%,P=1.0)。
- 非对称组5年全因无翻修生存率低于对称组(56.1%对85.5%,P=0.021)。
- 使用干骺端锥套时,两组5年非感染性无翻修生存率无显著差异(75.0%对97.0%,P=0.13;75.0%对82.5%,P=0.54)。
核心结论
- 对称胫骨垫块组影像学透亮线发生率与非对称组相似,但总体5年无翻修生存率更高。
- 当使用干骺端锥套时,对称与非对称胫骨垫块组的5年非感染性无翻修生存率相当。
研究设计与样本
- 回顾性队列研究(证据等级III),查询机构数据库2013年1月至2023年9月期间因无菌性翻修全膝关节置换术使用胫骨垫块的患者。
- 共纳入76例使用对称垫块和27例使用非对称垫块的患者,平均随访时间分别为3.5年(范围1.0至10.1年)和4.4年(范围1.0至8.8年)。
主要发现
- 非对称垫块组44.4%(12/27)患者存在影像学透亮线,对称垫块组44.7%(34/76)存在透亮线(P=1.0)。
- 整个队列5年全因无翻修生存率为76.6%。
- 非对称垫块组5年全因无翻修生存率低于对称组(56.1%对85.5%,P=0.021)。
- 非对称垫块组5年非感染性无翻修生存率低于对称组(64.8%对89%,P=0.019)。
- 对称垫块组非感染性翻修风险较非对称垫块组低84%(P=0.035)。
关键数值与推荐
- 亚组分析显示,使用干骺端锥套的非对称胫骨垫块组与使用干骺端锥套的对称胫骨垫块组5年非感染性无翻修生存率分别为75.0%和97.0%(P=0.13)。
- 使用干骺端锥套的非对称胫骨垫块组与不使用干骺端锥套的对称胫骨垫块组5年非感染性无翻修生存率分别为75.0%和82.5%(P=0.54)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study evaluated radiolucency in patients who underwent aseptic revision total knee arthroplasty using either symmetric or asymmetric modular tibial augments and compared 5-year all-cause and nonseptic revision-free survivorship between groups. METHODS: An institutional database was queried from January 2013 to September 2023 to identify patients who underwent aseptic revision total knee arthroplasty where tibial augments were utilized and were then stratified into symmetric and asymmetric tibial augment groups. Postoperative radiographs were reviewed for radiolucent lines through available follow-up. Kaplan-Meier survivorship curves were then created to compare rates of revision between both groups over 5 years. A total of 76 patients who had symmetrical augments and 27 patients who had asymmetrical augments were analyzed at a mean follow-up time of 3.5 years (range, 1.0 to 10.1) and 4.4 years (range, 1.0 to 8.8), respectively. RESULTS: Radiolucency was noted in 44.4% (12 of 27) of patients who had asymmetric augments and 44.7% (34 of 76) of those who had symmetric augments (P = 1.0). The 5-year all-cause revision-free survivorship for the entire cohort was 76.6%. The 5-year all-cause and nonseptic revision-free survival were lower in patients who had asymmetric tibial augments compared to symmetric (56.1 versus 85.5%; P = 0.021 and 64.8 versus 89%; P = 0.019, respectively). Patients who had symmetric tibial augments had 84% less risk of nonseptic revision when compared to patients who had asymmetric tibial augments (P = 0.035). Subanalysis demonstrated that asymmetric tibial augment constructs with metaphyseal cones had similar 5-year nonseptic revision-free survivorship to symmetric tibial augment constructs with (75.0 versus 97.0%; P = 0.13) or without metaphyseal cones (75.0 versus 82.5%; P = 0.54). CONCLUSIONS: Patients who had symmetric tibial augment constructs exhibited similar rates of radiolucency but higher survivorship compared to those with asymmetric constructs overall. However, when metaphyseal cones were utilized, survivorship was equivalent. LEVEL III EVIDENCE: Retrospective Cohort Study.
引用
- Leal J, Kugelman DN, Goel RK, et al. Comparing Survivorship of Symmetric Versus Asymmetric Tibial Augments in Aseptic Revision Total Knee Arthroplasty. J Arthroplasty. 2025. PMID: 40398576. doi:10.1016/j.arth.2025.05.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。